This Article Full Text (PDF) All Versions of this Article: 1077558707307577v1 65/1/114    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Domino, M. E. Articles by Yeh, W.-S. Search for Related Content PubMed PubMed Citation Articles by Domino, M. E. Articles by Yeh, W.-S. Pubmed/NCBI databases Medline Plus Health Information Medicare Prescription Drug Coverage Medicines Social Bookmarking                         What's this?

Why Using Current Medications to Select a Medicare Part D Plan May Lead to Higher Out-of-Pocket Payments

University of North Carolina at Chapel Hill

Sally C. Stearns

University of North Carolina at Chapel Hill

Edward C. Norton

University of North Carolina at Chapel Hill

Wei-Shi Yeh

University of North Carolina at Chapel Hill

While medications are one of the most stable categories of health care expenses, the actual composition of drug products used may be highly variable over time. Medicare beneficiaries selecting among Part D prescription drug plans (PDPs) are often advised to base plan selection on current medication lists. However, this approach may lead to higher out-of-pocket payments relative to payments under other plans if drug switches are common. This article uses a sample of Medicare beneficiaries from the 2003 Medical Expenditure Panel Survey to estimate how changes in actual drug use during a 1-year period affect estimated annual costs, given the initial choice of the lowest-cost PDP. While 57% of the sample had no difference in expenditure for plans selected based on initial versus end-of-the-year drug lists, 43% experienced average increases of $556 in annualized expenses due to drug switches. Implementable suggestions for improving the selection of Part D plans are provided.

Key Words: Medicare • prescription drugs • insurance • uncertainty

This version was published on February 1, 2008

Medical Care Research and Review, Vol. 65, No. 1, 114-126 (2008)
DOI: 10.1177/1077558707307577


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. R. Cummings, T. Rice, and Y. Hanoch Who Thinks That Part D Is Too Complicated?: Survey Results on the Medicare Prescription Drug Benefit Med Care Res Rev, February 1, 2009; 66(1): 97 - 115. [Abstract] [PDF]